Rossix.blue.jpg
Home Products About Us Contact

Chromogenic Kits

Learn more about our Chromogenic Kits.

Phospholipid Emulsions

Our highly stable phospholipid emulsions are suitable for use in analyses related to procoagulant and anticoagulant pathways.

References

Rossix will present the following posters at the ISTH in Melbourne July 6-10, 2019

Evaluation of Lupus Anticoagulant interference in a chromogenic Factor IX kit

for determination of Factor IX activity
P Bryngelhed1, R Hengeveld2, C Klopper-Tol2, F Ehklas2, S Rosén3, AK Stroobants2.

1Rossix AB, Mölndal, Sweden; 

2Amsterdam UMC, University of Amsterdam, Dept. of Clinical Chemistry, Amsterdam, the Netherlands; 

3Private Consultant, Kallered, Sweden


Abstract Presentation Number: PB0099
Date and Time of Poster Presentation: Sunday, 07 July 2019, 18:30-19:30
Poster Location: Exhibition Hall
_______________________________________________________________________________________

 

Assessment of Factor IX Padua activity with a one-stage clotting method and

with FXIa- and tissue factor/FVIIa-based chromogenic methods
S Rosén1, P Bryngelhed2, C Bulato3, P Simioni3.

1Private Consultancy, Kallered, Sweden 

2Rossix AB, Molndal, Sweden 

3University of Padua Medical School, Dept of Medicine, Padua, Italy

 

Abstract Presentation Number: PB1294
Date and Time of Poster Presentation: Tuesday, 09 July 2019, 18:30-19:30
Poster Location: Exhibition Hall
___________________________________________________________________________

 

Recombinant Factor IX fused with albumin (rFIX-HSA) is underassigned by

one-stage methods with silica as contact activator
S Rosén1, P Bryngelhed2

1Private Consultancy, Kallered, Sweden; 

2 Rossix AB, Mölndal, Sweden

 

Abstract Presentation Number: PB1295
Date and Time of Poster Presentation: Tuesday, 09 July 2019, 18:30-19:30
Poster Location: Exhibition Hall

News

2019-06-20 ISTH, Melbourne July 6-10, 2019.

Rossix will present three posters related to analysis of Factor IX at the ISTH in Melbourne:

PB0099 - Evaluation of Lupus Anticoagulant interference in a chromogenic Factor IX kit for determination of

Factor IX activity

PB1294 - Assessment of Factor IX Padua activity with a one-stage clotting method and with FXIa- and tissue factor/FVIIa-based chromogenic methods

PB1295 - Recombinant Factor IX fused with albumin (rFIX-HSA) is underassigned by one-stage methods with silica as contact activator

More information

  

2016-06-22 Publication in collaboration with NovoNordisk

Rosén P, Rosén S, Ezban M, Persson E.

Overestimation of N-glycoPEGylated factor IX activity in one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

J Thromb Haemost 2016; 14: 1420-7.

  

2015-04-13 Publication in collaboration with AstraZeneca

Ann Lövgren et al. Blood Coagulation and Fibrinolysis, Characterization of thrombin derived from 

human recombinant prothrombin.

Open access: click here

  

Search